BioHorizons launches xenograft products for dental implant site development

BioHorizons, an oral reconstructive device company, launched MinerOss X, a family of xenograft products for dental implant site development procedures.

Advertisement

The family of products includes cancellous or cortical particulate, a moldable collagen block and a cancellous particulate pre-loaded into a delivery syringe to assist with optimal placement. It is designed for extraction sockets, grafting for implant placement, ridge augmentation and sinus augmentation.

BioHorizons is a majority-owned subsidiary of Henry Schein.

More articles on oral care:

San Antonio ADA meeting to have $21M economic impact
5 dentists in the news
13 dentists on the move

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.